Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Number needed to treat is a simple measure of treatment efficacy for clinicians.

Rajkumar SV, Sampathkumar P, Gustafson AB.

J Gen Intern Med. 1996 Jun;11(6):357-9. No abstract available.

PMID:
8803742
2.

Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials.

Hutton JL.

Br J Haematol. 2009 Jun;146(1):27-30. doi: 10.1111/j.1365-2141.2009.07707.x. Epub 2009 Apr 27. Review.

PMID:
19438480
3.

Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

Suksomboon N, Poolsup N, Ket-Aim S.

J Clin Pharm Ther. 2007 Jun;32(3):293-311. Review.

PMID:
17489882
4.

Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.

Poolsup N, Leelasangaluk V, Jittangtrong J, Rithlamlert C, Ratanapantamanee N, Khanthong M.

J Clin Pharm Ther. 2005 Dec;30(6):521-32. Review.

PMID:
16336284
5.

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.

Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group.

J Clin Psychiatry. 2008 Sep;69(9):1404-15. Review.

PMID:
19193341
6.

Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities.

Gaynes BN.

J Clin Psychiatry. 2009;70 Suppl 6:10-5. doi: 10.4088/JCP.8133su1c.02. Review.

7.

Evidence-based dermatology: number needed to treat and its relation to other risk measures.

Manriquez JJ, Villouta MF, Williams HC.

J Am Acad Dermatol. 2007 Apr;56(4):664-71. Epub 2006 Oct 27. Review.

PMID:
17367615
9.

A simple measure of reliability in clinical trials of surgical adjuvant radiotherapy.

Ochel HJ.

Eur J Surg Oncol. 2006 May;32(4):395-9. Epub 2006 Feb 28. Review.

PMID:
16504457
10.
11.

An update: women, hypertension and therapeutic efficacy.

Jones CA, Nagpal S.

Can J Cardiol. 2001 Dec;17(12):1283-9. Review.

PMID:
11773939
12.

Further evidence of the need to establish treatment safety as well as efficacy in randomized controlled trials.

Tonkin AM, Dujovne CA.

Curr Opin Lipidol. 2002 Dec;13(6):591-3. Review. No abstract available.

PMID:
12441882
13.

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials.

Sultan A, Gaskell H, Derry S, Moore RA.

BMC Neurol. 2008 Aug 1;8:29. doi: 10.1186/1471-2377-8-29. Review.

14.

Compelling or irrelevant? Using number needed to treat can help decide.

Citrome L.

Acta Psychiatr Scand. 2008 Jun;117(6):412-9. doi: 10.1111/j.1600-0447.2008.01194.x. Review.

PMID:
18479317
15.

The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis.

Schmitt R, Gazalle FK, Lima MS, Cunha A, Souza J, Kapczinski F.

Rev Bras Psiquiatr. 2005 Mar;27(1):18-24. Epub 2005 Apr 18. Review.

16.

Are better endpoints and better design of clinical trials needed?

Fransen J, van Riel PL.

Best Pract Res Clin Rheumatol. 2004 Feb;18(1):97-109. Review.

PMID:
15123040
18.

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.

Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New-Generation Antidepressants (MANGA) Study Group.

CNS Drugs. 2008;22(7):587-602. Review.

PMID:
18547127
19.

Carbon monoxide poisoning: interpretation of randomized clinical trials and unresolved treatment issues.

Hampson NB, Mathieu D, Piantadosi CA, Thom SR, Weaver LK.

Undersea Hyperb Med. 2001 Fall;28(3):157-64. Review.

PMID:
12067152

Supplemental Content

Support Center